Ascor® (ascorbic acid) – New drug approval
October 3, 2017 – McGuff Pharmaceuticals announced the FDA approval of Ascor (ascorbic acid) injection, for short term (up to 1 week) treatment of scurvy in adult and pediatric patients, age 5 months and older, for whom oral administration is not possible, insufficient or contraindicated.
Top